Role of caspase 8 as a determinant in chemosensitivity of p53-mutated head and neck squamous cell carcinoma cell lines

We studied factors that control chemoresistanceto 6 head and neck squamous cell carcinomacell lines carrying p53 mutations. Cell lines werechosen, based on the presence of EGFR amplifications,the presence of H-ras mutations, and theabsence of either. WST-1 viability assays showedthat, in response to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of Medical and Dental Sciences 2006, Vol.53(1), pp.57-66
Hauptverfasser: Kaneda, Yoshimasa, Shimamoto, Hiroaki, Matsumura, Kouji, Arvind, Ramanathan, Zhang, Shengliang, Sakai, Eiki, Omura, Ken, Tsuchida, Nobuo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 66
container_issue 1
container_start_page 57
container_title Journal of Medical and Dental Sciences
container_volume 53
creator Kaneda, Yoshimasa
Shimamoto, Hiroaki
Matsumura, Kouji
Arvind, Ramanathan
Zhang, Shengliang
Sakai, Eiki
Omura, Ken
Tsuchida, Nobuo
description We studied factors that control chemoresistanceto 6 head and neck squamous cell carcinomacell lines carrying p53 mutations. Cell lines werechosen, based on the presence of EGFR amplifications,the presence of H-ras mutations, and theabsence of either. WST-1 viability assays showedthat, in response to etoposide, Ca922 was mostsensitive, HOC313 most resistant, and HSC6 andthe others moderately sensitive. A similar tendencywas shown by further analyses with cisplatin, 5-fluorouracil,LY294002, and combined treatment withLY294002 and TNF-related apoptosis-inducing ligand(TRAIL). Although both Ca922 and HOC313 hadactivating mutations upstream of Akt signaling, theconstitutive phosphorylation of Akt at S473 wasobserved in chemosensitive Ca922, but not inchemoresistant HOC313, suggesting that constitutiveAkt phosphorylation was not the primarydeterminant for chemoresistance in these celllines. Further, by the combined treatment withLY294002 and TRAIL, apoptosis was induced inCa922 and HSC6 but not in HOC313. Interestingly,caspase 8 was not detected in HOC313, while itwas cleaved in the other 2 cell lines. Further, inCa922 and HSC6 but not in HOC313, caspase 8inhibitor restored loss of viability induced eitherwith LY294002 and TRAIL or even with etoposidealone. These findings suggest that caspase 8played an important role in chemoresistanceagainst genotoxic drugs.
doi_str_mv 10.11480/jmds.530108
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_68005396</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68005396</sourcerecordid><originalsourceid>FETCH-LOGICAL-j481t-f8286a0dca8fa96a75a87444cd841bd64cc5b5201bd39a65024c7544c7b2f6223</originalsourceid><addsrcrecordid>eNo9kU1v1DAQhi0EoqvSG2fkE7cUf8c5VhUUpEpICM7WxJ6wXhJnGzuV-u_rKKWXmbHe149nPIR85Oyac2XZl9MU8rWWjDP7hhwEt7rpuBRvyYFLJRprObsgVznHngnJdct1955ccNMKwZU5kMdf84h0HqiHfIaM1FLIFGjAgssUE6RCY6L-iNOcMeVY4mMsT9uNs5bNtBYoGOgRIVBIgSb0_2h-WGGa10w9jmMlLz6meYL9OMaE-QN5N8CY8eolX5I_377-vv3e3P-8-3F7c9-clOWlGaywBljwYAfoDLQabKuU8sEq3gejvNe9FqzWsgOjmVC-1VVvezEYIeQl-bxzz8v8sGIubop5awMS1gadsYxp2Zlq_PRiXPsJgzsvcYLlyf3_qWq42w1VjR7GOW2DuNO8LqlO4HDsqoLZCcaM26iM12S3sq3B1HY6bkRXSTc76ZQL_MXXp2Ap0Y8VWVfqtHR8C_tqXzV_hMVhks_VFJlw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68005396</pqid></control><display><type>article</type><title>Role of caspase 8 as a determinant in chemosensitivity of p53-mutated head and neck squamous cell carcinoma cell lines</title><source>J-STAGE Free</source><source>MEDLINE</source><source>Freely Accessible Japanese Titles</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Kaneda, Yoshimasa ; Shimamoto, Hiroaki ; Matsumura, Kouji ; Arvind, Ramanathan ; Zhang, Shengliang ; Sakai, Eiki ; Omura, Ken ; Tsuchida, Nobuo</creator><creatorcontrib>Kaneda, Yoshimasa ; Shimamoto, Hiroaki ; Matsumura, Kouji ; Arvind, Ramanathan ; Zhang, Shengliang ; Sakai, Eiki ; Omura, Ken ; Tsuchida, Nobuo ; Tokyo Medical and Dental University ; Laboratory of Cell Analysis ; Central Research Institute ; Department of Molecular Cellular Oncology and Microbiology ; Oral and Maxillofacial Surgery ; Dokkyo University School of Medicine ; National Defense Medical College ; Department of Oral and Maxillofacial Surgery</creatorcontrib><description>We studied factors that control chemoresistanceto 6 head and neck squamous cell carcinomacell lines carrying p53 mutations. Cell lines werechosen, based on the presence of EGFR amplifications,the presence of H-ras mutations, and theabsence of either. WST-1 viability assays showedthat, in response to etoposide, Ca922 was mostsensitive, HOC313 most resistant, and HSC6 andthe others moderately sensitive. A similar tendencywas shown by further analyses with cisplatin, 5-fluorouracil,LY294002, and combined treatment withLY294002 and TNF-related apoptosis-inducing ligand(TRAIL). Although both Ca922 and HOC313 hadactivating mutations upstream of Akt signaling, theconstitutive phosphorylation of Akt at S473 wasobserved in chemosensitive Ca922, but not inchemoresistant HOC313, suggesting that constitutiveAkt phosphorylation was not the primarydeterminant for chemoresistance in these celllines. Further, by the combined treatment withLY294002 and TRAIL, apoptosis was induced inCa922 and HSC6 but not in HOC313. Interestingly,caspase 8 was not detected in HOC313, while itwas cleaved in the other 2 cell lines. Further, inCa922 and HSC6 but not in HOC313, caspase 8inhibitor restored loss of viability induced eitherwith LY294002 and TRAIL or even with etoposidealone. These findings suggest that caspase 8played an important role in chemoresistanceagainst genotoxic drugs.</description><identifier>ISSN: 1342-8810</identifier><identifier>EISSN: 2185-9132</identifier><identifier>DOI: 10.11480/jmds.530108</identifier><identifier>PMID: 16722146</identifier><language>eng</language><publisher>Japan: Tokyo Medical and Dental University (TMDU)</publisher><subject>Akt ; Antineoplastic Agents - pharmacology ; Apoptosis - drug effects ; Apoptosis Regulatory Proteins - pharmacology ; Carcinoma, Squamous Cell - enzymology ; Carcinoma, Squamous Cell - genetics ; Caspase 8 ; Caspases - physiology ; Cell Line, Tumor - drug effects ; Cell Line, Tumor - enzymology ; Chromones - pharmacology ; Cisplatin - pharmacology ; Dentistry ; Drug Resistance, Neoplasm - genetics ; Drug Resistance, Neoplasm - physiology ; etoposide ; Etoposide - pharmacology ; Fluorouracil - pharmacology ; Head and Neck Neoplasms - enzymology ; Head and Neck Neoplasms - genetics ; head and neck squamous cell carcinoma ; Humans ; Membrane Glycoproteins - pharmacology ; Morpholines - pharmacology ; Mutation ; Phosphorylation ; Proto-Oncogene Proteins c-akt - metabolism ; TNF-Related Apoptosis-Inducing Ligand ; TRAIL ; Tumor Necrosis Factor-alpha - pharmacology ; Tumor Suppressor Protein p53 - genetics</subject><ispartof>Journal of Medical and Dental Sciences, 2006, Vol.53(1), pp.57-66</ispartof><rights>2006 Tokyo Medical and Dental University (TMDU)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1877,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16722146$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kaneda, Yoshimasa</creatorcontrib><creatorcontrib>Shimamoto, Hiroaki</creatorcontrib><creatorcontrib>Matsumura, Kouji</creatorcontrib><creatorcontrib>Arvind, Ramanathan</creatorcontrib><creatorcontrib>Zhang, Shengliang</creatorcontrib><creatorcontrib>Sakai, Eiki</creatorcontrib><creatorcontrib>Omura, Ken</creatorcontrib><creatorcontrib>Tsuchida, Nobuo</creatorcontrib><creatorcontrib>Tokyo Medical and Dental University</creatorcontrib><creatorcontrib>Laboratory of Cell Analysis</creatorcontrib><creatorcontrib>Central Research Institute</creatorcontrib><creatorcontrib>Department of Molecular Cellular Oncology and Microbiology</creatorcontrib><creatorcontrib>Oral and Maxillofacial Surgery</creatorcontrib><creatorcontrib>Dokkyo University School of Medicine</creatorcontrib><creatorcontrib>National Defense Medical College</creatorcontrib><creatorcontrib>Department of Oral and Maxillofacial Surgery</creatorcontrib><title>Role of caspase 8 as a determinant in chemosensitivity of p53-mutated head and neck squamous cell carcinoma cell lines</title><title>Journal of Medical and Dental Sciences</title><addtitle>J. med. dent. sci.</addtitle><description>We studied factors that control chemoresistanceto 6 head and neck squamous cell carcinomacell lines carrying p53 mutations. Cell lines werechosen, based on the presence of EGFR amplifications,the presence of H-ras mutations, and theabsence of either. WST-1 viability assays showedthat, in response to etoposide, Ca922 was mostsensitive, HOC313 most resistant, and HSC6 andthe others moderately sensitive. A similar tendencywas shown by further analyses with cisplatin, 5-fluorouracil,LY294002, and combined treatment withLY294002 and TNF-related apoptosis-inducing ligand(TRAIL). Although both Ca922 and HOC313 hadactivating mutations upstream of Akt signaling, theconstitutive phosphorylation of Akt at S473 wasobserved in chemosensitive Ca922, but not inchemoresistant HOC313, suggesting that constitutiveAkt phosphorylation was not the primarydeterminant for chemoresistance in these celllines. Further, by the combined treatment withLY294002 and TRAIL, apoptosis was induced inCa922 and HSC6 but not in HOC313. Interestingly,caspase 8 was not detected in HOC313, while itwas cleaved in the other 2 cell lines. Further, inCa922 and HSC6 but not in HOC313, caspase 8inhibitor restored loss of viability induced eitherwith LY294002 and TRAIL or even with etoposidealone. These findings suggest that caspase 8played an important role in chemoresistanceagainst genotoxic drugs.</description><subject>Akt</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Apoptosis - drug effects</subject><subject>Apoptosis Regulatory Proteins - pharmacology</subject><subject>Carcinoma, Squamous Cell - enzymology</subject><subject>Carcinoma, Squamous Cell - genetics</subject><subject>Caspase 8</subject><subject>Caspases - physiology</subject><subject>Cell Line, Tumor - drug effects</subject><subject>Cell Line, Tumor - enzymology</subject><subject>Chromones - pharmacology</subject><subject>Cisplatin - pharmacology</subject><subject>Dentistry</subject><subject>Drug Resistance, Neoplasm - genetics</subject><subject>Drug Resistance, Neoplasm - physiology</subject><subject>etoposide</subject><subject>Etoposide - pharmacology</subject><subject>Fluorouracil - pharmacology</subject><subject>Head and Neck Neoplasms - enzymology</subject><subject>Head and Neck Neoplasms - genetics</subject><subject>head and neck squamous cell carcinoma</subject><subject>Humans</subject><subject>Membrane Glycoproteins - pharmacology</subject><subject>Morpholines - pharmacology</subject><subject>Mutation</subject><subject>Phosphorylation</subject><subject>Proto-Oncogene Proteins c-akt - metabolism</subject><subject>TNF-Related Apoptosis-Inducing Ligand</subject><subject>TRAIL</subject><subject>Tumor Necrosis Factor-alpha - pharmacology</subject><subject>Tumor Suppressor Protein p53 - genetics</subject><issn>1342-8810</issn><issn>2185-9132</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kU1v1DAQhi0EoqvSG2fkE7cUf8c5VhUUpEpICM7WxJ6wXhJnGzuV-u_rKKWXmbHe149nPIR85Oyac2XZl9MU8rWWjDP7hhwEt7rpuBRvyYFLJRprObsgVznHngnJdct1955ccNMKwZU5kMdf84h0HqiHfIaM1FLIFGjAgssUE6RCY6L-iNOcMeVY4mMsT9uNs5bNtBYoGOgRIVBIgSb0_2h-WGGa10w9jmMlLz6meYL9OMaE-QN5N8CY8eolX5I_377-vv3e3P-8-3F7c9-clOWlGaywBljwYAfoDLQabKuU8sEq3gejvNe9FqzWsgOjmVC-1VVvezEYIeQl-bxzz8v8sGIubop5awMS1gadsYxp2Zlq_PRiXPsJgzsvcYLlyf3_qWq42w1VjR7GOW2DuNO8LqlO4HDsqoLZCcaM26iM12S3sq3B1HY6bkRXSTc76ZQL_MXXp2Ap0Y8VWVfqtHR8C_tqXzV_hMVhks_VFJlw</recordid><startdate>200603</startdate><enddate>200603</enddate><creator>Kaneda, Yoshimasa</creator><creator>Shimamoto, Hiroaki</creator><creator>Matsumura, Kouji</creator><creator>Arvind, Ramanathan</creator><creator>Zhang, Shengliang</creator><creator>Sakai, Eiki</creator><creator>Omura, Ken</creator><creator>Tsuchida, Nobuo</creator><general>Tokyo Medical and Dental University (TMDU)</general><general>Tokyo Medical and Dental University</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200603</creationdate><title>Role of caspase 8 as a determinant in chemosensitivity of p53-mutated head and neck squamous cell carcinoma cell lines</title><author>Kaneda, Yoshimasa ; Shimamoto, Hiroaki ; Matsumura, Kouji ; Arvind, Ramanathan ; Zhang, Shengliang ; Sakai, Eiki ; Omura, Ken ; Tsuchida, Nobuo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-j481t-f8286a0dca8fa96a75a87444cd841bd64cc5b5201bd39a65024c7544c7b2f6223</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Akt</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Apoptosis - drug effects</topic><topic>Apoptosis Regulatory Proteins - pharmacology</topic><topic>Carcinoma, Squamous Cell - enzymology</topic><topic>Carcinoma, Squamous Cell - genetics</topic><topic>Caspase 8</topic><topic>Caspases - physiology</topic><topic>Cell Line, Tumor - drug effects</topic><topic>Cell Line, Tumor - enzymology</topic><topic>Chromones - pharmacology</topic><topic>Cisplatin - pharmacology</topic><topic>Dentistry</topic><topic>Drug Resistance, Neoplasm - genetics</topic><topic>Drug Resistance, Neoplasm - physiology</topic><topic>etoposide</topic><topic>Etoposide - pharmacology</topic><topic>Fluorouracil - pharmacology</topic><topic>Head and Neck Neoplasms - enzymology</topic><topic>Head and Neck Neoplasms - genetics</topic><topic>head and neck squamous cell carcinoma</topic><topic>Humans</topic><topic>Membrane Glycoproteins - pharmacology</topic><topic>Morpholines - pharmacology</topic><topic>Mutation</topic><topic>Phosphorylation</topic><topic>Proto-Oncogene Proteins c-akt - metabolism</topic><topic>TNF-Related Apoptosis-Inducing Ligand</topic><topic>TRAIL</topic><topic>Tumor Necrosis Factor-alpha - pharmacology</topic><topic>Tumor Suppressor Protein p53 - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kaneda, Yoshimasa</creatorcontrib><creatorcontrib>Shimamoto, Hiroaki</creatorcontrib><creatorcontrib>Matsumura, Kouji</creatorcontrib><creatorcontrib>Arvind, Ramanathan</creatorcontrib><creatorcontrib>Zhang, Shengliang</creatorcontrib><creatorcontrib>Sakai, Eiki</creatorcontrib><creatorcontrib>Omura, Ken</creatorcontrib><creatorcontrib>Tsuchida, Nobuo</creatorcontrib><creatorcontrib>Tokyo Medical and Dental University</creatorcontrib><creatorcontrib>Laboratory of Cell Analysis</creatorcontrib><creatorcontrib>Central Research Institute</creatorcontrib><creatorcontrib>Department of Molecular Cellular Oncology and Microbiology</creatorcontrib><creatorcontrib>Oral and Maxillofacial Surgery</creatorcontrib><creatorcontrib>Dokkyo University School of Medicine</creatorcontrib><creatorcontrib>National Defense Medical College</creatorcontrib><creatorcontrib>Department of Oral and Maxillofacial Surgery</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of Medical and Dental Sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kaneda, Yoshimasa</au><au>Shimamoto, Hiroaki</au><au>Matsumura, Kouji</au><au>Arvind, Ramanathan</au><au>Zhang, Shengliang</au><au>Sakai, Eiki</au><au>Omura, Ken</au><au>Tsuchida, Nobuo</au><aucorp>Tokyo Medical and Dental University</aucorp><aucorp>Laboratory of Cell Analysis</aucorp><aucorp>Central Research Institute</aucorp><aucorp>Department of Molecular Cellular Oncology and Microbiology</aucorp><aucorp>Oral and Maxillofacial Surgery</aucorp><aucorp>Dokkyo University School of Medicine</aucorp><aucorp>National Defense Medical College</aucorp><aucorp>Department of Oral and Maxillofacial Surgery</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of caspase 8 as a determinant in chemosensitivity of p53-mutated head and neck squamous cell carcinoma cell lines</atitle><jtitle>Journal of Medical and Dental Sciences</jtitle><addtitle>J. med. dent. sci.</addtitle><date>2006-03</date><risdate>2006</risdate><volume>53</volume><issue>1</issue><spage>57</spage><epage>66</epage><pages>57-66</pages><issn>1342-8810</issn><eissn>2185-9132</eissn><abstract>We studied factors that control chemoresistanceto 6 head and neck squamous cell carcinomacell lines carrying p53 mutations. Cell lines werechosen, based on the presence of EGFR amplifications,the presence of H-ras mutations, and theabsence of either. WST-1 viability assays showedthat, in response to etoposide, Ca922 was mostsensitive, HOC313 most resistant, and HSC6 andthe others moderately sensitive. A similar tendencywas shown by further analyses with cisplatin, 5-fluorouracil,LY294002, and combined treatment withLY294002 and TNF-related apoptosis-inducing ligand(TRAIL). Although both Ca922 and HOC313 hadactivating mutations upstream of Akt signaling, theconstitutive phosphorylation of Akt at S473 wasobserved in chemosensitive Ca922, but not inchemoresistant HOC313, suggesting that constitutiveAkt phosphorylation was not the primarydeterminant for chemoresistance in these celllines. Further, by the combined treatment withLY294002 and TRAIL, apoptosis was induced inCa922 and HSC6 but not in HOC313. Interestingly,caspase 8 was not detected in HOC313, while itwas cleaved in the other 2 cell lines. Further, inCa922 and HSC6 but not in HOC313, caspase 8inhibitor restored loss of viability induced eitherwith LY294002 and TRAIL or even with etoposidealone. These findings suggest that caspase 8played an important role in chemoresistanceagainst genotoxic drugs.</abstract><cop>Japan</cop><pub>Tokyo Medical and Dental University (TMDU)</pub><pmid>16722146</pmid><doi>10.11480/jmds.530108</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1342-8810
ispartof Journal of Medical and Dental Sciences, 2006, Vol.53(1), pp.57-66
issn 1342-8810
2185-9132
language eng
recordid cdi_proquest_miscellaneous_68005396
source J-STAGE Free; MEDLINE; Freely Accessible Japanese Titles; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Akt
Antineoplastic Agents - pharmacology
Apoptosis - drug effects
Apoptosis Regulatory Proteins - pharmacology
Carcinoma, Squamous Cell - enzymology
Carcinoma, Squamous Cell - genetics
Caspase 8
Caspases - physiology
Cell Line, Tumor - drug effects
Cell Line, Tumor - enzymology
Chromones - pharmacology
Cisplatin - pharmacology
Dentistry
Drug Resistance, Neoplasm - genetics
Drug Resistance, Neoplasm - physiology
etoposide
Etoposide - pharmacology
Fluorouracil - pharmacology
Head and Neck Neoplasms - enzymology
Head and Neck Neoplasms - genetics
head and neck squamous cell carcinoma
Humans
Membrane Glycoproteins - pharmacology
Morpholines - pharmacology
Mutation
Phosphorylation
Proto-Oncogene Proteins c-akt - metabolism
TNF-Related Apoptosis-Inducing Ligand
TRAIL
Tumor Necrosis Factor-alpha - pharmacology
Tumor Suppressor Protein p53 - genetics
title Role of caspase 8 as a determinant in chemosensitivity of p53-mutated head and neck squamous cell carcinoma cell lines
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T01%3A50%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20caspase%208%20as%20a%20determinant%20in%20chemosensitivity%20of%20p53-mutated%20head%20and%20neck%20squamous%20cell%20carcinoma%20cell%20lines&rft.jtitle=Journal%20of%20Medical%20and%20Dental%20Sciences&rft.au=Kaneda,%20Yoshimasa&rft.aucorp=Tokyo%20Medical%20and%20Dental%20University&rft.date=2006-03&rft.volume=53&rft.issue=1&rft.spage=57&rft.epage=66&rft.pages=57-66&rft.issn=1342-8810&rft.eissn=2185-9132&rft_id=info:doi/10.11480/jmds.530108&rft_dat=%3Cproquest_pubme%3E68005396%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68005396&rft_id=info:pmid/16722146&rfr_iscdi=true